EN
HI
Summary
As of 15 Nov, 2026, Aarti Drugs stock price is ₹507.35. During the trading session, the stock has moved between an intraday low of ₹502.90 and an intraday high of ₹527.50. Over the last 52 weeks, Aarti Drugs has traded between ₹318.95 and ₹527.50.
The stock has recorded a trading volume of 15,60,298 shares,. Its Average Traded Price (ATP) is ₹517.72, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹507.35.
Aarti Drugs has an upper circuit limit of ₹608.80 and a lower circuit limit of ₹405.90. The total value traded stands at ₹80.78 CR, and the delivery percentage for the day is 37.4%.
The stock is currently traded with a market lot size of 1. Aarti Drugs also offers a dividend yield of 0.39%.
Aarti Drugs Share Price Chart
Aarti Drugs Share Key Metrics
Volume
15.60 L
Market Cap
4630.58 CR
LTQ@LTP
50@507.35
ATP
517.72
Var Margin
18.57 %
Circuit Range
405.9-608.8
Delivery %
37.4 %
Value
80.78 CR
ASM/GSM
No
Market Lot
1
Aarti Drugs Fundamentals
P/E Ratio
20.24
P/B Ratio
2.75
Div. Yield
0.39
Sector P/E
41.18
Sector P/B
2.49
Sec. Div. Yield
0.53
Aarti Drugs Resistance and Support
Pivot 503.03
Resistance
First Resistance
519.81
Second Resistance
530.88
Third Resistance
547.66
Support
First Support
491.96
Second Support
475.18
Third Support
464.11
Aarti Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 509.2 | 507.35 | -0.28% | 527.5 | 502.9 |
| Thu Nov 12 2026 | 491 | 508.75 | 3.84% | 514.09 | 486.25 |
| Wed Nov 11 2026 | 497.2 | 489.95 | -1.96% | 507.64 | 484 |
Aarti Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-27 | Employees Stock Option Plan |
| 2026-07-31 | Quarterly Results |
| 2026-05-15 | Audited Results |
| 2026-02-03 | Quarterly Results & Interim Dividend |
| 2025-11-07 | Quarterly Results |
| 2025-07-18 | Quarterly Results |
| 2025-05-06 | Audited Results |
| 2025-01-29 | Quarterly Results & Interim Dividend |
| 2024-10-24 | Quarterly Results |
| 2024-08-26 | Buy Back of Shares |
| 2024-07-26 | Quarterly Results |
Aarti Drugs News
Aarti Drugs Ltd - 524348 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Aarti Drugs' subsidiary Pinnacle Life Science received 3 inspectional observations in Form 483 from the US FDA for its Baddi formulation facility. The company stated there are no data integrity issues and no impact on operations.
Nov 06 2026 17:03:55
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aarti Drugs reported its highest-ever Q2 FY27 cons. revenue of Rs.828.8 crores, up 27% YoY, and a PAT of Rs.82.8 crores, up 83% YoY. The growth was broad-based, with the specialty chemicals business growing 92% YoY and formulations growing 58% YoY.
Nov 03 2026 21:17:16
Read More
Aarti Drugs Management
| Name | Position |
|---|---|
| Rushikesh Deole | Company Secretary & Compliance Officer |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Drugs Similar Stocks
Artemis Medicare Services Ltd.
321.80
5.05 (1.59%)
Gujarat Themis Biosyn Ltd.
388.65
1.10 (0.28%)
SMS Pharmaceuticals Ltd.
508.05
-15.80 (3.02%)
Gufic Biosciences Ltd.
473.05
-13.95 (2.86%)
RPG Life Sciences Ltd.
2551.30
-51.90 (1.99%)
Kwality Pharmaceuticals Ltd.
3822.60
-126.10 (3.19%)
Indraprastha Medical Corporation Ltd.
330.15
-6.10 (1.81%)
Shukra Medtech Ltd.
82.23
0.03 (0.04%)
Unichem Laboratories Ltd.
498.75
1.65 (0.33%)
Aarti Drugs FAQs
The Buying Price of Aarti Drugs share is 507.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Drugs shares is 20.24. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Drugs shares is 2.75. Useful to assess the stock's value relative to its book value.
To assess Aarti Drugs’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Drugs is 4630.58 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Drugs share price is 527.50 & 318.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIDRUGS
Or Download Choice FinX App
Invest in AARTIDRUGS
